alendronate has been researched along with Proteinuria in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a case of collapsing focal segmental glomerulosclerosis and severe kidney dysfunction in a liver transplant recipient after the initiation of alendronate for osteopenia." | 7.74 | Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate. ( Djamali, A; Musat, A; Myers, J; Pascual, J; Samaniego, M; Tome, S; Torrealba, J, 2007) |
| "We describe a case of collapsing focal segmental glomerulosclerosis and severe kidney dysfunction in a liver transplant recipient after the initiation of alendronate for osteopenia." | 3.74 | Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate. ( Djamali, A; Musat, A; Myers, J; Pascual, J; Samaniego, M; Tome, S; Torrealba, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miura, N | 1 |
| Mizuno, N | 1 |
| Aoyama, R | 1 |
| Kitagawa, W | 1 |
| Yamada, H | 1 |
| Nishikawa, K | 1 |
| Imai, H | 1 |
| Pascual, J | 1 |
| Torrealba, J | 1 |
| Myers, J | 1 |
| Tome, S | 1 |
| Samaniego, M | 1 |
| Musat, A | 1 |
| Djamali, A | 1 |
2 other studies available for alendronate and Proteinuria
| Article | Year |
|---|---|
Massive proteinuria and acute renal failure after oral bisphosphonate (alendronate) administration in a patient with focal segmental glomerulosclerosis.
Topics: Acute Kidney Injury; Administration, Oral; Alendronate; Blood Component Removal; Bone Density Conser | 2009 |
Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate.
Topics: Alendronate; Bone Density Conservation Agents; Bone Diseases, Metabolic; Glomerulosclerosis, Focal S | 2007 |